POFUT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.684800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.003800E-01
Normal-vs-Stage2
6.659600E-01
Normal-vs-Stage3
5.184400E-01
Normal-vs-Stage4
4.259800E-01
Stage1-vs-Stage2
6.247800E-01
Stage1-vs-Stage3
1.277650E-01
Stage1-vs-Stage4
3.130200E-01
Stage2-vs-Stage3
1.762980E-01
Stage2-vs-Stage4
6.827800E-01
Stage3-vs-Stage4
9.468300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.778000E-01
Normal-vs-AfricanAmerican
2.668600E-01
Normal-vs-Asian
8.877600E-01
Caucasian-vs-AfricanAmerican
2.206400E-01
Caucasian-vs-Asian
2.854000E-01
AfricanAmerican-vs-Asian
1.025030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.313000E-01
Normal-vs-Female
5.886400E-01
Male-vs-Female
4.410000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.583600E-01
Normal-vs-Age(41-60Yrs)
3.247400E-01
Normal-vs-Age(61-80Yrs)
8.165200E-01
Normal-vs-Age(81-100Yrs)
9.131800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.170800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.676000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.316600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.371500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.142570E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.994000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.707600E-01
Normal-vs-Daily Drinker
9.104400E-01
Normal-vs-Weekly Drinker
6.777000E-01
Normal-vs-Occasional Drinker
3.028800E-01
Normal-vs-Social Drinker
3.881200E-01
Non Drinker-vs-Daily Drinker
2.805000E-01
Non Drinker-vs-Weekly Drinker
1.719770E-01
Non Drinker-vs-Occasional Drinker
1.957120E-03
Non Drinker-vs-Social Drinker
6.598000E-03
Daily Drinker-vs-Weekly Drinker
4.857000E-01
Daily Drinker-vs-Occasional Drinker
8.399700E-02
Daily Drinker-vs-Social Drinker
1.342200E-01
Weekly Drinker-vs-Occasional Drinker
4.931800E-01
Weekly Drinker-vs-Social Drinker
5.651200E-01
Occasional Drinker-vs-Social Drinker
9.661400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.418800E-01
Normal-vs-Grade 2
8.523000E-01
Normal-vs-Grade 3
8.882200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.264600E-01
Grade 1-vs-Grade 3
3.748200E-01
Grade 1-vs-Grade 4
8.418800E-01
Grade 2-vs-Grade 3
2.869600E-01
Grade 2-vs-Grade 4
8.523000E-01
Grade 3-vs-Grade 4
8.882200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.755000E-01
Normal-vs-NonDiabetic
6.282000E-01
Diabetic-vs-NonDiabetic
4.490400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.345200E-01
Normal-vs-NoPancreatitis
7.261200E-01
Pancreatitis-vs-NoPancreatitis
8.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.862600E-01
Normal-vs-N1
6.413600E-01
N0-vs-N1
5.811600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.804000E-01
Normal-vs-TP53-NonMutant
6.592000E-01
TP53-Mutant-vs-TP53-NonMutant
1.027440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
